Règlement grand-ducal du 3 novembre 2020 fixant les conditions de réalisation de prélèvements nasopharyngés, oropharyngés, buccaux ou salivaires afin de réaliser des tests diagnostiques ou de dépistage de l’infection par virus SARS-CoV-2.
This preamble introduces a regulation on the conditions for collecting nasopharyngeal, oropharyngeal, buccal, or saliva samples for SARS-CoV-2 diagnostic or screening tests.
AI-assisted research synopsis — verify against the official legal text below.
- Jurisdiction
- Luxembourg
- Instrument
- Regulation
- Citation
- http://data.legilux.public.lu/eli/etat/leg/rgd/2020/11/03/a882/jo
- Status
- Repealed
- Version
- Undated source snapshot
- Language
- fr
- Updated
- Official source
- View official record ↗
Publicly available, excluded from search-engine indexing
This page remains available for direct access and API use, but this release emits
noindex,follow for the following reason:
- The record does not meet this release's canonical indexing criteria.
(market-indexing-disabled)
Statute overview
About this statute
This preamble introduces a regulation on the conditions for collecting nasopharyngeal, oropharyngeal, buccal, or saliva samples for SARS-CoV-2 diagnostic or screening tests. This provision defines “prélèvement” as certain nasal, throat, mouth, or saliva samples used for diagnosing or screening SARS-CoV-2. A blood draw or similar prélèvement may be performed on a person only if the person is informed and gives free, informed consent, and only by the listed health and rescue professionals. Certain people under Article 2 must complete training before the sampling takes place, and that training must be approved by the minister responsible for Health. The health minister is responsible for carrying out this regulation, and it is to be published in the Official Journal of Luxembourg.
Ask AI about this statute
Règlement grand-ducal du 3 novembre 2020 fixant les conditions de réalisation de prélèvements nasopharyngés, oropharyngés, buccaux ou salivaires afin de réaliser des tests diagnostiques ou de dépistage de l’infection par virus SARS-CoV-2.
Sign in to ask AI about this statute
Sign in to start authenticated, citation-grounded statute research.
Sign in